Latest Hospitality News

Page 4 of 81
Doctor Care Anywhere’s Q3 revenue rose 16% to £11.3 million as its weight-management business delivered its first full quarter, lifting subscription revenue to 19% of the total. The unaudited update also shows modest consultation growth, higher cash and three new distribution partnerships.
Ada Torres
Ada Torres
30 Oct 2026
ImpediMed lifted quarterly revenue and recurring revenue, but weaker-than-expected BCRL sales and a near-total sales team rebuild have put its path to cash-flow break-even under pressure. The company ended September with $11.6 million in cash and 4.7 quarters of funding at the quarter’s operating burn.
Ada Torres
Ada Torres
30 Oct 2026
Swift TV expanded its contracted footprint and qualified pipeline in the September quarter, but ended with $1.047 million in cash and only 0.9 quarters of funding at the reported burn rate. The company is relying on customer receipts, an expected $1.5 million R&D incentive and lending arrangements as commercial deployments accelerate.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Hydrix reported September-quarter revenue growth of 11.6% year on year and secured further medical and Defence milestones. But with $1.5 million in cash and reported funding covering only 1.30 quarters, the company still needs contract wins to convert into receipts and revenue.
Sophie Babbage
Sophie Babbage
29 Oct 2026
Aeris Environmental has reported stable quarterly revenue and fresh commercial traction for its Syncromesh platform, but ended September with $840,000 in cash against a $1.201 million operating cash outflow. An October $1.5 million placement provides additional funding, while $11.153 million in related-party loans remain due in June 2027.
Victor Sage
Victor Sage
29 Oct 2026
Transmetro Corporation (ASX:TCO) delivered a 50% increase in FY2026 net profit to A$4.49 million, while cash rose to A$13.94 million and the fully franked dividend increased to 6 cents per share. The debt-free hotel operator is preparing to open Metro Hotel Martin Place Sydney and support a major refurbishment of its 220-room Marlow property.
Victor Sage
Victor Sage
29 Oct 2026
Cyclopharm has reported record third-quarter US Technegas revenue of A$1.62 million, with 76% generated by recurring consumable orders. Its installed base and hospital pipeline expanded sharply after new clinical guidelines preferred Technegas when available, while quarterly cash burn fell to A$0.9 million.
Ada Torres
Ada Torres
29 Oct 2026
Integral Diagnostics has opened FY27 below expectations, with radiologist and sonographer shortages limiting revenue growth and pushing labour costs ahead of sales. The company expects FY27 revenue growth of 4% to 6% and a full-year operating EBITDA margin of 19.5% to 20.5%, with improvement weighted to the second half.
Ada Torres
Ada Torres
29 Oct 2026
NRW Holdings has added approximately $334 million of disclosed contract value through a one-year Curragh Mine extension and new Canberra infrastructure packages. The awards give both its mining and Fredon businesses work commencing in early 2027, although margins and earnings contributions remain undisclosed.
Victor Sage
Victor Sage
29 Oct 2026
Alcidion has started FY27 with contracted revenue up 38% to $50.0 million, while a major UK expansion and new patient administration product widen its growth case. The company has also reaffirmed that FY27 revenue and underlying EBITDA will exceed FY26, but its capital plan now has several competing demands.
Victor Sage
Victor Sage
29 Oct 2026
PainChek is concentrating its commercial effort on residential aged care after signing new US and UK business, including an 808-licence Sabra expansion and an approximately 1,800-licence Hallmark contract. Revenue and retention improved, but activated ARR growth slowed to 1.2% for the quarter and cash covered an estimated 2.5 quarters of historical operating outflows.
Victor Sage
Victor Sage
28 Oct 2026
IMEXHS has moved several proprietary AI agents into live customer use while delivering stronger revenue, earnings and operating cash flow in the third quarter. But software bookings fell sharply, ARR was flat after churn, and Colombian receivables remain a material cash risk.
Victor Sage
Victor Sage
28 Oct 2026

Browse the archive

Full archive